Current research: Oncology data fitness and descriptive analysis. The consortium will evaluate the current data capabilities of the BBCIC distributed research networks and identify additional data sources to enrich BBCIC capabilities in measures relevant to oncology outcome.
Press Release: Alexandria, Va., Jan. 25, 2017 — The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) is pleased to announce the addition of a new participating organization, Apobiologix.
Press release: Alexandria, Va. October 27, 2015 -- (AMCP) today announced a major milestone in the formation of the Biologics & Biosimilars Collective Intelligence Consortium (BBCIC).
BBCIC is a non-profit research consortium that monitors the safety and effectiveness of biosimilars and novel biologics and provides the assurance needed to determine which medications deliver the best health outcomes.
